X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com//news-release/2024/02/06/2824260/0/en/Cybrexa-Regains-Rights-to-CBX-12.html
https://www.globenewswire.com//news-release/2023/10/10/2757453/0/en/Cybrexa-Therapeutics-to-Debut-Preclinical-Data-Demonstrating-CBX-15-is-Safe-and-Highly-Efficacious-in-13762-Triple-Negative-Breast-Cancer-Model-at-35th-AACR-NCI-EORTC-Symposium.html
https://www.globenewswire.com/news-release/2023/05/25/2676765/0/en/Cybrexa-Therapeutics-To-Present-Data-at-ASCO-2023-Highlighting-First-In-Human-Dose-Finding-Study-of-Lead-Candidate-CBX-12.html
https://www.globenewswire.com/news-release/2023/04/12/2645274/0/en/Cybrexa-Appoints-Jaya-Gautam-as-Senior-Vice-President-of-Technical-Operations.html
https://www.globenewswire.com/news-release/2023/02/01/2599421/0/en/Cybrexa-Strengthens-Drug-Development-Capabilities-with-the-Addition-of-Laurie-Kenvin-to-the-Company-s-Leadership-Team-and-Nick-Saccomano-to-the-SAB.html
https://www.globenewswire.com/news-release/2022/12/15/2574399/0/en/Cybrexa-Therapeutics-Announces-the-Appointment-of-Michael-N-Needle-MD-as-Senior-Vice-President-and-Chief-Medical-Officer.html
https://www.globenewswire.com/news-release/2022/10/28/2543909/0/en/Cybrexa-Therapeutics-Presents-Findings-from-First-in-Human-Study-of-CBX-12-as-a-Plenary-Oral-Presentation-at-34th-EORTC-NCI-AACR-Symposium.html
https://www.globenewswire.com/news-release/2022/06/02/2455211/0/en/Cybrexa-Therapeutics-to-Present-at-Upcoming-Investor-Conferences-in-June.html
https://www.globenewswire.com/news-release/2021/10/26/2320568/0/en/Cybrexa-Therapeutics-Announces-Data-Demonstrating-Early-Signals-of-Efficacy-and-Powerful-Potential-of-Antigen-Independent-Tumor-Targeting.html
Market Place
Share 
